CONSUMATORI Condizioni di vendita Contatti Cerca Sitemap HOME INTEGRATORI QUALITA' CERTIFICATA TESTIMONIANZE OMEGA-3 RICERCA E SALUTE Il FARMACISTA CONSIGLIA LIBRI OMEGOR IN FARMACIA RISORSE Bibliografia Scientifica Domande e Risposte Glossario NEWSLETTER U.G.A. NUTRACEUTICALS E-SHOP OMEGOR   RISORSE / Bibliografia Scientifica Torna al menu pagina  1 2 Salute del bambino Aman, M.G., Mitchell, E.A., and Turbott, S.H. (1987) "The effects of essential fatty acid supplementation by Efamol in hyperactive children." J Abnorm Child Psychol. 15(1):75-90. vai Arnold, L.E., Kleykamp, D., Votolato, N.A., Taylor, W.A., Kontras, S.B., Tobin, K. (1989) "Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine." Biol Psychiatry. 25(2):222-8. Department of Psychiatry, Ohio State University, Columbus. vai Burgess, J. R., L. Stevens, et al. (2000). "Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder." Am J Clin Nutr 71 (1): 327-330. vai Colquhoun, I., Bunday, S. (1981) "A lack of essential fatty acids as a possible cause of hyperactivity in children." Med Hypotheses. 7(5):673-9 vai Konofal, E., Lecendreux, M., Arnulf, I., Mouren, M.C. (2004) "Iron deficiency in children with attention-deficit/hyperactivity disorder." Arch Pediatr Adolesc Med. 158(12):1113-5. Service de Psychopathologie de l'Enfant et de l'Adolescent, Hopital Robert Debre, Paris, France. vai Mitchell, E.A., Aman, M.G., Turbott, S.H., Manku, M. (1987) "Clinical characteristics and serum essential fatty acid levels in hyperactive children." Clin Pediatr (Phila). 26(8):406-11. vai Torna al menu pagina  1 2

Credits ©2006-2010 - U.G.A. Nutraceuticals S.r.l. - P.IVA 02801680543     Company Info